Quantum Biopharma (QNTM) Price to Book (2019 - 2026)

Quantum Biopharma has disclosed Price to Book across 8 years of filings, most recently posting 2.31 for Q2 2026.

• In Q2 2026, Price to Book fell 79.47% year-over-year to 2.31; the TTM figure through Jun 2026 stood at 2.31 (down 79.47% YoY), while the FY2025 annual figure was 5.56, up 1287.9% from the prior year.
• Price to Book came in at 2.31 for Q2 2026 at Quantum Biopharma, up from 13.22 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 206.74 in Q3 2023 to a low of 13.22 in Q1 2026.
• Average Price to Book over 5 years is 60.54, with a median of 36.48 recorded in 2022.
• Year-over-year, Price to Book jumped 1287.9% in 2025 and slumped 783.3% in 2026.
• Over 5 years, Price to Book stood at 64.96 in 2022, then soared by 113.45% to 138.65 in 2023, then sank by 99.71% to 0.4 in 2024, then jumped by 1287.9% to 5.56 in 2025, then sank by 58.48% to 2.31 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 2.31 in Q2 2026, 13.22 in Q1 2026, and 5.56 in Q4 2025.